{"denomUnitsSelected":"Participants","description":"Pharmacokinetic parameters including peak and trough levels will be determined by noncompartmental method(s) using the pharmacokinetic profile of entospletinib and obinutuzumab.","reportingStatus":"NOT_POSTED","timeFrame":"Up to 45 months","title":"Pharmacodynamics Parameters of NFkappaB Activation and Expression of Anti-apoptotic Proteins in Chronic Lymphocytic Leukemia (CLL) Cells","type":"OTHER_PRE_SPECIFIED"}